CHICAGO, September 4, 2024 — Vyaire Medical has entered into a definitive agreement with ZOLL Medical Corporation related to the sale of the Vyaire Ventilation Business Unit. The transaction has received approval from the US Bankruptcy Court for the District of Delaware, and the parties will now work to close the transaction in the coming weeks.

“This agreement is an important step in delivering on our commitment to sell our Ventilation Business Unit to a well-capitalized buyer who can support the growth and development of the Vyaire Ventilation product portfolio,” said John Bibb, Group Chief Executive Officer, Vyaire. “Vyaire and ZOLL have aligned values and shared business objectives built on improving patient outcomes and helping save lives.” 

ZOLL is a global leader in acute critical care and related software and diagnostic tools. ZOLL medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions.

“ZOLL’s mission and values are a great fit for the Vyaire Ventilation team and portfolio,” added Tammy Noll, Chief Executive Officer, Vyaire Ventilation. “ZOLL has the right experience and business structure to support the future of Vyaire Ventilation while we continue delivering for our customers and their patients.”

Vyaire anticipates closing the transaction in the coming weeks. Until then, Vyaire will continue to fully manage its Ventilation business and products, with full support to customers, and will work to ensure continuity for partners and suppliers. The sale to ZOLL does not include the iX5™ product line and associated operations, which Vyaire will continue to market to other interested bidders.

_________________________________

About Vyaire Medical

Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. Established from legacy brands with a 70-year history of pioneering breathing technology, the integrated solutions offered by the company’s Ventilation and Respiratory Diagnostics (RDx) businesses help enable, enhance, and extend lives. Vyaire products are available in more than 100 countries and are recognized, trusted, and preferred by specialists throughout the respiratory community worldwide.

Vyaire Ventilation is committed to delivering the right therapy to every patient in all respiratory care settings with the express purpose of enhancing medical outcomes. Learn more about Vyaire Ventilation.